Nav: ₹ 493.7170 ↓ -0.58%
[as on 24 September, 2025]
Nav chart with 500 day SMA
Returns
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | -1.01% | -0.58% | -0.76% | -1.63% | 3.27% | 3.17% | 27.22% | 21.87% | 20.34% | 12.37% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Cash & Equivalents |
|---|
| 96.19% |
0.07% |
0.00% |
3.74% |
Equity
| Name | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | 10.86% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | 6.81% |
| Max Healthcare Institute Ltd. | Healthcare Services | 6.12% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | 4.81% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | 4.02% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 3.59% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.49% |
| Fortis Healthcare Ltd. | Healthcare Services | 3.45% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | 3.31% |
| Krishna Institute of Medical Sciences Ltd. | Healthcare Services | 3.20% |
| Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | 3.19% |
| Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | 3.06% |
| Aster DM Healthcare Ltd. | Healthcare Services | 3.03% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | 3.03% |
| Polymedicure Ltd. | Healthcare Equipment & Supplies | 2.98% |
| Jupiter Life Line Hospitals Ltd. | Healthcare Services | 2.90% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | 2.86% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | 2.81% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | 2.68% |
| Aether Industries Ltd. | Chemicals & Petrochemicals | 2.60% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | 2.48% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | 2.12% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | 1.82% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | 1.78% |
| Vijaya Diagnostic Centre Ltd. | Healthcare Services | 1.53% |
| Pfizer Ltd. | Pharmaceuticals & Biotechnology | 1.30% |
| Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals & Biotechnology | 0.98% |
| Gufic Biosciences Ltd. | Pharmaceuticals & Biotechnology | 0.93% |
| Akums Drugs & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | 0.13% |
| Medplus Health Services Ltd. | Retailing | 0.08% |
| Lonza Group | Pharmaceuticals & Biotechnology | 4.24% |
Debt
| Name | Rating | Weight % |
|---|
| 182 DAY T-BILL 20.11.25 | Sovereign | 0.07% |
Portfolio data is as on date 31 August, 2025
FAQ (Frequently asked questions)
What is latest/current NAV/price of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The latest NAV of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH is 493.7170 as on 24 September, 2025.
What are YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The YTD (year to date) returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are -1.01% as on 24 September, 2025.
What are 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 1 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 3.17% as on 24 September, 2025.
What are 3 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 3 year annualized returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 27.22% as on 24 September, 2025.
What are 5 year returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH?
The 5 year annualized returns of SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH are 21.87% as on 24 September, 2025.
